Filing Flows

Filing Flows › Mereo BioPharma Group (MREO) › Next earnings date

Mereo BioPharma Group (MREO) earnings on Nov 9, 2026: what to expect

Mereo BioPharma Group (MREO) is expected to report earnings on Nov 9, 2026 (estimated), tomorrow, for the quarter ending Sep 30, 2026. Analysts expect EPS of −$0.01 (−$0.03 to −$0.01, 6 estimates), against −$0.01 a year ago. It beat the EPS estimate in 0% of the quarters on record; Filing Flows' model gives it a 38% chance of beating next time.

Report dateNov 9, 2026 (estimated)
Days to go1
EPS estimate−$0.01
Beat rate0%

The last report

Mereo BioPharma Group reported revenue of $500K for the second quarter 2025, net loss $14.6M. How it makes money → · Every quarter →

Mereo BioPharma Group: EPS against the estimate, last 4 reportsMereo BioPharma Group: EPS against the estimate, last 4 reportsEstimateReported−$0.00−$0.01Nov 25−$0.01−$0.01Mar 26$0.00−$0.01May 26−$0.01−$0.01Aug 26
Latest (Aug 26): Estimate −$0.01, Reported −$0.01.

Mereo BioPharma Group's latest quarter

Mereo BioPharma Group, Q2 2025: revenue $500K, net loss $14.6M, operating cash flow −$7.7M. The chart follows the revenue to costs, profit and cash.

Questions

When does MREO report earnings?

Mereo BioPharma Group is expected to report on Nov 9, 2026 (estimated).

What are analysts expecting from Mereo BioPharma Group?

EPS of −$0.01 for the quarter.

Does Mereo BioPharma Group usually beat earnings?

It beat the consensus EPS estimate in 0% of the quarters on record.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.